Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 10/20 | 0.51 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.50 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.48 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21437126 | 0.99 | TRPV1 (0.50) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437341 | 0.96 | TRPV1 (0.52) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437409 | 0.96 | TRPV1 (0.52) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437354 | 0.96 | TRPV1 (0.52) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437035 | 0.96 | TRPV1 (0.52) | TRPV1TLR8EHMT2EHMT1MAPT | |
| SCHEMBL22919736 | 0.94 | EHMT2 (0.56) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437349 | 0.93 | EHMT2 (0.53) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437413 | 0.93 | EHMT2 (0.55) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437255 | 0.93 | EHMT2 (0.55) | TRPV1TLR8EHMT2EHMT1MAPT | |
| Hydrochloric Acid SCHEMBL21437363 | 0.93 | EHMT2 (0.55) | TRPV1TLR8EHMT2EHMT1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138583-A1 | SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS | OHIO STATE INNOVATION FOUNDATION | 2023-05-04 | — | — | US | disclosed |
| US-20230138583-A1 | SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS | OHIO STATE INNOVATION FOUNDATION | 2023-05-04 | — | — | US | disclosed |
| US-20210023060-A1 | SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS | NORTH CAROLINA STATE UNIVERSITY | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210023060-A1 | SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS | ITGB3, ITGB2, ITGAM | TRPV1 1481/4885TLR8 1381/4885EHMT2 1620/4885 |
| US-20230138583-A1 | SUBSTITUTED 2-AMINOBENZIMIDAZOLES ANALOGS AS ANTIBIOFILM AGENTS | ITGB3, ITGB2, ITGAM | TRPV1 1481/4885TLR8 1381/4885EHMT2 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.